For many physicians, discussing political beliefs or controversial advocacy work with patients seems inappropriate or even unethical, though many patients may have no problem with it.
How to Prepare for the Aftermath of COVID-19
Here are key practices providers should focus on to create a safer, more stable environment for patients while remaining vigilant for a COVID-19 resurgence.
Leading Virtual Meetings with Physicians Amid Coronavirus Pandemic
The need for social distancing triggered by coronavirus requires a change in physician-to-physician interactions from in-person meetings to virtual.
Challenges of Treating Patients Who Are Also Physicians and How to Overcome Them
Common challenges when treating physician-patients include maintaining boundaries and avoiding assumptions about patient knowledge and behaviors.
Ageism in Medicine: A Look at Medical Ethics, Laws, and Regulations
Ageism can hurt both physicians and patients. Here’s a look at the federal and state laws surrounding ageism.
Telemedicine: A Look at Recent Reforms Expanding Access, Use Amid Coronavirus Crisis
Recent changes in state and federal laws have made telemedicine services more likely to be covered and reimbursed by insurance companies, benefitting both providers and patients.
How to Launch a Practice in the Millennial Age
Otolaryngologists rely on a mix of old and new tactics to attract patients.
Read This Before Agreeing to a Private Equity Deal
Physician practices need a clear understanding of why private equity may be a good option. Here’s what you need to know before agreeing to a deal.
Changes to Federal Laws May Mean Better Collaboration Between Healthcare Providers
Proposed changes to the the U.S. healthcare system’s primary fraud and abuse laws were finally unveiled in October 2019. Here’s what the reforms mean for physicians.
How to Work with Sales and Marketing Representatives in Your Medical Practice
The decision to engage saled and marketing representives should be made carefully because the arrangements are subject to significant scrutiny under the federal Anti-Kickback Statute (AKS) and state equivalents.
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 49
- Next Page »